188 related articles for article (PubMed ID: 28969563)
21. Functionalization and cancer-targeting design of ruthenium complexes for precise cancer therapy.
Liu J; Lai H; Xiong Z; Chen B; Chen T
Chem Commun (Camb); 2019 Aug; 55(67):9904-9914. PubMed ID: 31360938
[TBL] [Abstract][Full Text] [Related]
22. Biological activity and cellular uptake of [Ru(η5-C5H5)(PPh3)(Me2bpy)][CF3SO3] complex.
Morais TS; Santos F; Côrte-Real L; Marques F; Robalo MP; Madeira PJ; Garcia MH
J Inorg Biochem; 2013 May; 122():8-17. PubMed ID: 23416310
[TBL] [Abstract][Full Text] [Related]
23. Multinuclear Organometallic Ruthenium-Arene Complexes for Cancer Therapy.
Babak MV; Ang WH
Met Ions Life Sci; 2018 Feb; 18():. PubMed ID: 29394025
[TBL] [Abstract][Full Text] [Related]
24. Polymer "ruthenium-cyclopentadienyl" conjugates - New emerging anti-cancer drugs.
Moreira T; Francisco R; Comsa E; Duban-Deweer S; Labas V; Teixeira-Gomes AP; Combes-Soia L; Marques F; Matos A; Favrelle A; Rousseau C; Zinck P; Falson P; Garcia MH; Preto A; Valente A
Eur J Med Chem; 2019 Apr; 168():373-384. PubMed ID: 30826512
[TBL] [Abstract][Full Text] [Related]
25. Structural basis and anticancer properties of ruthenium-based drug complexed with human serum albumin.
Zhang Y; Ho A; Yue J; Kong L; Zhou Z; Wu X; Yang F; Liang H
Eur J Med Chem; 2014 Oct; 86():449-55. PubMed ID: 25200980
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of interactions between platinum-/ruthenium-based anticancer agents and human serum albumin: development of HSA carrier for metal-based drugs.
Gou Y; Zhang Y; Yang F; Liang H
Curr Pharm Des; 2015; 21(14):1848-61. PubMed ID: 25732554
[TBL] [Abstract][Full Text] [Related]
27. A Cancer Cell-Selective and Low-Toxic Bifunctional Heterodinuclear Pt(IV)-Ru(II) Anticancer Prodrug.
Ma L; Lin X; Li C; Xu Z; Chan CY; Tse MK; Shi P; Zhu G
Inorg Chem; 2018 Mar; 57(5):2917-2924. PubMed ID: 29436828
[TBL] [Abstract][Full Text] [Related]
28. Cisplatin: The first metal based anticancer drug.
Ghosh S
Bioorg Chem; 2019 Jul; 88():102925. PubMed ID: 31003078
[TBL] [Abstract][Full Text] [Related]
29. Heterodinuclear Pt(iv)-Ru(ii) anticancer prodrugs to combat both drug resistance and tumor metastasis.
Ma L; Ma R; Wang Z; Yiu SM; Zhu G
Chem Commun (Camb); 2016 Sep; 52(71):10735-8. PubMed ID: 27506281
[TBL] [Abstract][Full Text] [Related]
30. The mechanism of action of platinum anticancer agents--what do we really know about it?
Gibson D
Dalton Trans; 2009 Dec; (48):10681-9. PubMed ID: 20023895
[TBL] [Abstract][Full Text] [Related]
31. Stimuli-Responsive Therapeutic Metallodrugs.
Wang X; Wang X; Jin S; Muhammad N; Guo Z
Chem Rev; 2019 Jan; 119(2):1138-1192. PubMed ID: 30299085
[TBL] [Abstract][Full Text] [Related]
32. Metal-based anticancer chemotherapeutic agents.
Muhammad N; Guo Z
Curr Opin Chem Biol; 2014 Apr; 19():144-53. PubMed ID: 24608084
[TBL] [Abstract][Full Text] [Related]
33. Recent Advancements in Organotin(IV) Complexes as Potent Cytotoxic Agents.
Devi J; Boora A; Rani M; Arora T
Anticancer Agents Med Chem; 2023; 23(2):164-191. PubMed ID: 35619310
[TBL] [Abstract][Full Text] [Related]
34. [RuII(η⁵-C₅H₅)(bipy)(PPh₃)]⁺, a promising large spectrum antitumor agent: cytotoxic activity and interaction with human serum albumin.
Tomaz AI; Jakusch T; Morais TS; Marques F; de Almeida RF; Mendes F; Enyedy EA; Santos I; Pessoa JC; Kiss T; Garcia MH
J Inorg Biochem; 2012 Dec; 117():261-9. PubMed ID: 22877927
[TBL] [Abstract][Full Text] [Related]
35. New applications of old metal-binding drugs in the treatment of human cancer.
Schmitt SM; Frezza M; Dou QP
Front Biosci (Schol Ed); 2012 Jan; 4(1):375-91. PubMed ID: 22202066
[TBL] [Abstract][Full Text] [Related]
36. Transport of therapeutic vanadium and ruthenium complexes by blood plasma components.
Pessoa JC; Tomaz I
Curr Med Chem; 2010; 17(31):3701-38. PubMed ID: 20846109
[TBL] [Abstract][Full Text] [Related]
37. Preface.
Prudhomme M
Anticancer Agents Med Chem; 2017; 17(1):3. PubMed ID: 28143384
[No Abstract] [Full Text] [Related]
38. Imine-N-Heterocyclic Carbenes as Versatile Ligands in Ruthenium(II) p-Cymene Anticancer Complexes: A Structure-Activity Relationship Study.
Yang Y; Guo L; Tian Z; Liu X; Gong Y; Zheng H; Ge X; Liu Z
Chem Asian J; 2018 Oct; 13(19):2923-2933. PubMed ID: 30101417
[TBL] [Abstract][Full Text] [Related]
39. Antiproliferative activity of dmoPTA-Ru(II) complexes against human solid tumor cells.
Ríos-Luci C; León LG; Mena-Cruz A; Pérez-Roth E; Lorenzo-Luis P; Romerosa A; Padrón JM
Bioorg Med Chem Lett; 2011 Aug; 21(15):4568-71. PubMed ID: 21719285
[TBL] [Abstract][Full Text] [Related]
40. Serendipitous Synthesis of Five-Coordinated Half-Sandwich Aminoimine Iridium(III) and Ruthenium(II) Complexes and Their Application as Potent Anticancer Agents.
Du Q; Guo L; Ge X; Zhao L; Tian Z; Liu X; Zhang F; Liu Z
Inorg Chem; 2019 May; 58(9):5956-5965. PubMed ID: 30986046
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
